DHH-B: The Botanical Anxiolytic Examined

DHH-B (dihydrohonokiol-B) is a compound derived from honokiol in magnolia bark that appears to enhance GABA-A receptor signaling, the same calming system targeted by benzodiazepines. In mice it reduced anxiety-like behavior with fewer benzodiazepine-like side effects, but controlled human trials are essentially absent. It is not a peptide and not an FDA-approved drug.

Patients increasingly ask me about DHH-B because it shows up in "calm" and "sleep" products and in peptide-clinic menus. It is worth understanding clearly, both for what is promising and for where the evidence simply stops.

What Is DHH-B?

Magnolia bark has a long history in traditional East Asian medicine. Its two best-studied constituents are honokiol and magnolol, both small polyphenol molecules. DHH-B is a partially hydrogenated derivative of honokiol, developed and studied because it appeared more potent than honokiol itself in early animal models.

Two points of clarity:

• DHH-B is not a peptide. It appears in peptide reference guides, including my own teaching material, because it is often discussed alongside sleep and stress peptides, not because of its chemistry.
• It is not an FDA-approved medicine. It is sold in some supplement products. As of this writing, its regulatory status as a supplement ingredient is not something I would assume; check current FDA guidance, and remember that supplements are not reviewed for effectiveness before sale.

How DHH-B Is Thought to Work

GABA-A modulation

GABA is the brain's main inhibitory neurotransmitter. The GABA-A receptor is a chloride channel that, when activated, quiets neuronal firing. Benzodiazepines, many sleep medications and alcohol all act on this receptor in different ways.

Honokiol and related compounds appear to be positive allosteric modulators of GABA-A receptors, meaning they make the receptor respond more strongly to the GABA already present. That is the proposed basis for DHH-B's calming effect.

Why "without sedation" is a claim, not a fact

The key selling point of DHH-B is anxiety relief without the drowsiness, memory problems, tolerance and dependence associated with benzodiazepines. The origin of that claim is real: a 2000 study in mice found that dihydrohonokiol reduced anxiety-like behavior at doses that did not produce the motor impairment, amnesia-like effects or dependence-like effects seen with diazepam.

That is encouraging. But mice are not people, receptor subtype effects can differ across species, and anxiety in humans is far more complex than behavior in a maze. "Fewer side effects in mice" should not be translated into "no side effects in humans."

What the Evidence Shows, Honestly

• Animal data: Several rodent studies of honokiol and dihydrohonokiol show anxiolytic-like effects, with dihydrohonokiol appearing potent.
• Human data on magnolia extracts: Small studies of combination products containing magnolia bark extract have looked at stress and sleep with modest, mixed results. These are not studies of purified DHH-B.
• Human data on DHH-B itself: Largely anecdotal reports. Anecdotes are useful for generating questions, not for answering them.

When I discuss DHH-B with patients, I describe it as an interesting, under-studied compound rather than a validated treatment.

Safety Considerations

Because human data are limited, safety thinking relies on mechanism and on what is known about related compounds:

• Additive sedation: Anything that enhances GABA-A signaling can add to the effects of alcohol, benzodiazepines, Z-drugs (such as zolpidem), opioids, gabapentinoids and sedating antihistamines.
• Driving and machinery: Until you know how you respond, assume it may impair alertness.
• Pregnancy and breastfeeding: No safety data; avoid.
• Liver and drug metabolism: Honokiol has shown effects on drug-metabolizing enzymes in laboratory studies. The clinical significance is unknown, which is a reason to review your full medication list first.
• Product quality: Supplement content can vary from the label.

Dosing is individualized and discussed only after evaluation. I do not publish protocols for compounds without established human dosing data.

Anxiety and Sleep Deserve a Real Workup

Before any calming compound, I want to know why someone is anxious or sleeping poorly. In internal medicine, those symptoms can come from:

• Thyroid overactivity, anemia or iron deficiency
• Obstructive sleep apnea
• Caffeine, alcohol, nicotine or stimulant medications
• Perimenopause and other hormonal transitions
• Low blood sugar episodes, heart rhythm problems, or chronic pain
• Generalized anxiety disorder, panic disorder, depression or PTSD, which have effective, evidence-based treatments including therapy and medications

At Laeeq M.D., we look at these first, with labs and a careful history. The foundations, such as consistent sleep timing, morning light, alcohol reduction, exercise and structured stress practices, often help more than any single compound. I go deeper on this in stress and cortisol management in high performers and sleep architecture and hormonal restoration.

How DHH-B Compares With Other "Calm" Compounds

Patients sometimes ask about Selank, a peptide studied in Russia for anxiety, or about DSIP for sleep. Each has its own small evidence base, and Selank has been restricted for compounding in the U.S. You can read more in Selank and Semax: Russia's cognitive peptides examined. None of these is a substitute for diagnosis.

Sources

• Kuribara H, et al. Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects? — Journal of Pharmacy and Pharmacology, 2000. https://pubmed.ncbi.nlm.nih.gov/11007074/

Book a Consultation

If anxiety or poor sleep is affecting your life, a thoughtful evaluation is the best place to start, whether or not supplements are part of the plan. You can book a consultation for a 60-minute visit with Dr. Laeeq, virtually or in Reston, VA, to review your history, labs and options.

This article is for educational purposes and is not medical advice. Discuss any treatment with a licensed physician who knows your history.